Onconetix, Inc. Payments for Advance to Affiliate
Onconetix, Inc. (ONCO) reported Payments for Advance to Affiliate of $229.80 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2024-12-10.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForAdvanceToAffiliate · last filed 2024-12-10
- Onconetix, Inc. payments for advance to affiliate for the quarter ending 2023-09-30 was -$224.76K.
| Period end | Payments for Advance to Affiliate 3 month | Payments for Advance to Affiliate 6 month | Payments for Advance to Affiliate 9 month |
|---|---|---|---|
| 2023-09-30 | -$224.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-12-10 | $229.80K 10-Q · filed 2024-12-10 | |
| 2023-06-30 | $454.56K 10-Q · filed 2024-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |